{"pmid":32425655,"pmcid":"PMC7233331","title":"Elective procedures for prostate cancer in the time of Covid-19: a multidisciplinary team experience.","text":["Elective procedures for prostate cancer in the time of Covid-19: a multidisciplinary team experience.","On March 29th 2020, 97,689 cases of COVID-19 have been diagnosed only in Italy, with 73,880 actually positive cases, a daily increase of 3815 cases, 27,386 hospitalized and 3906 patients in intensive care units, causing a total of 10,779 known deaths. In all urological departments, quickly inpatient and outpatient services have been significantly reduced. Even in this COVID-19 situation, urological neoplasm care must go on, but significant changes need to be made in the way some care is delivered. We compared diagnostic and therapeutic elective procedures requested and performed for PC management from our multidisciplinary team (MDT) during 1 month activity in the highest national level of COVID-19 infection (March 2020) and under restrictions for all the population, with the management performed in a no-COVID-19 month (March 2019) 1 year ago. The only management that did not received a significant reduction are medical therapies for advanced hormone sensitive (HS) or castration resistant (CR) PC. We describe our MDT identifications of elective undeferrable PC management in this COVID-19 time. These suggestions have been considered for a country (ITALY) under a rapid increase of COVID-19 cases and complications, but in a region with an actual lower impact (2914 actual positive and 1079 hospitalized cases) from the infection and in an hospital not completely converted to COVID-19 management. Indications should be different and restricted only to emergencies on the basis of COVID-19 pandemic situation and hospital involvement.","Prostate Cancer Prostatic Dis","Sciarra, Alessandro","Salciccia, Stefano","Maggi, Martina","Del Giudice, Francesco","Busetto, Gian Maria","Musio, Daniela","Ciardi, Antonio","Catalano, Carlo","Cortesi, Enrico","Panebianco, Valeria","32425655"],"abstract":["On March 29th 2020, 97,689 cases of COVID-19 have been diagnosed only in Italy, with 73,880 actually positive cases, a daily increase of 3815 cases, 27,386 hospitalized and 3906 patients in intensive care units, causing a total of 10,779 known deaths. In all urological departments, quickly inpatient and outpatient services have been significantly reduced. Even in this COVID-19 situation, urological neoplasm care must go on, but significant changes need to be made in the way some care is delivered. We compared diagnostic and therapeutic elective procedures requested and performed for PC management from our multidisciplinary team (MDT) during 1 month activity in the highest national level of COVID-19 infection (March 2020) and under restrictions for all the population, with the management performed in a no-COVID-19 month (March 2019) 1 year ago. The only management that did not received a significant reduction are medical therapies for advanced hormone sensitive (HS) or castration resistant (CR) PC. We describe our MDT identifications of elective undeferrable PC management in this COVID-19 time. These suggestions have been considered for a country (ITALY) under a rapid increase of COVID-19 cases and complications, but in a region with an actual lower impact (2914 actual positive and 1079 hospitalized cases) from the infection and in an hospital not completely converted to COVID-19 management. Indications should be different and restricted only to emergencies on the basis of COVID-19 pandemic situation and hospital involvement."],"journal":"Prostate Cancer Prostatic Dis","authors":["Sciarra, Alessandro","Salciccia, Stefano","Maggi, Martina","Del Giudice, Francesco","Busetto, Gian Maria","Musio, Daniela","Ciardi, Antonio","Catalano, Carlo","Cortesi, Enrico","Panebianco, Valeria"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32425655","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1038/s41391-020-0240-4","keywords":["cancer therapy","prostate cancer"],"locations":["Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1667352728861409280,"score":9.490897,"similar":[{"pmid":32283219,"pmcid":"PMC7151239","title":"Rapid Implementation of Inpatient Telepalliative Medicine Consultations During COVID-19 Pandemic.","text":["Rapid Implementation of Inpatient Telepalliative Medicine Consultations During COVID-19 Pandemic.","As coronavirus disease 2019 cases increase throughout the country and health care systems grapple with the need to decrease provider exposure and minimize personal protective equipment use while maintaining high-quality patient care, our specialty is called on to consider new methods of delivering inpatient palliative care (PC). Telepalliative medicine has been used to great effect in outpatient and home-based PC but has had fewer applications in the inpatient setting. As we plan for decreased provider availability because of quarantine and redeployment and seek to reach increasingly isolated hospitalized patients in the face of coronavirus disease 2019, the need for telepalliative medicine in the inpatient setting is now clear. We describe our rapid and ongoing implementation of telepalliative medicine consultation for our inpatient PC teams and discuss lessons learned and recommendations for programs considering similar care models.","J Pain Symptom Manage","Humphreys, Jessi","Schoenherr, Laura","Elia, Giovanni","Saks, Naomi Tzril","Brown, Chelsea","Barbour, Susan","Pantilat, Steven Z","32283219"],"abstract":["As coronavirus disease 2019 cases increase throughout the country and health care systems grapple with the need to decrease provider exposure and minimize personal protective equipment use while maintaining high-quality patient care, our specialty is called on to consider new methods of delivering inpatient palliative care (PC). Telepalliative medicine has been used to great effect in outpatient and home-based PC but has had fewer applications in the inpatient setting. As we plan for decreased provider availability because of quarantine and redeployment and seek to reach increasingly isolated hospitalized patients in the face of coronavirus disease 2019, the need for telepalliative medicine in the inpatient setting is now clear. We describe our rapid and ongoing implementation of telepalliative medicine consultation for our inpatient PC teams and discuss lessons learned and recommendations for programs considering similar care models."],"journal":"J Pain Symptom Manage","authors":["Humphreys, Jessi","Schoenherr, Laura","Elia, Giovanni","Saks, Naomi Tzril","Brown, Chelsea","Barbour, Susan","Pantilat, Steven Z"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32283219","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jpainsymman.2020.04.001","keywords":["covid-19","inpatient","coronavirus","hospital medicine","telehealth","telemedicine"],"topics":["Prevention"],"weight":1,"_version_":1666138491546763265,"score":236.42036},{"pmid":32424990,"title":"Martini-Klinik experience on prostate cancer surgery during the early phase of COVID-19.","text":["Martini-Klinik experience on prostate cancer surgery during the early phase of COVID-19.","In order to restrain an uncontrolled spread of the 2019 Coronavirus-Disease (COVID-19) and to provide sufficient intensive-care unit (ICU) capacity, medical specializations needed to develop new routines and risk-strategy protocols. Those restrictions have also impacted the urologic community. Several medical organisations developed specific information-hubs, blogs and resource centers on how to tackle the COVID-19 situation (1-3). Although the German Society of Urology (\"DGU\") has published a recommendation to evaluate the need for a timely therapy in prostate cancer (PCa) patients according to D'Amico risk groups on the 2(nd) of April 2020, up to now no compulsory directives exist regarding omitting radical prostatectomy (RP) during the COVID-19 pandemic.","BJU Int","Wurnschimmel, Christoph","Maurer, Tobias","Knipper, Sophie","von Breunig, Franziska","Zoellner, Christian","Thederan, Imke","Huland, Hartwig","Graefen, Markus","Michl, Uwe","32424990"],"abstract":["In order to restrain an uncontrolled spread of the 2019 Coronavirus-Disease (COVID-19) and to provide sufficient intensive-care unit (ICU) capacity, medical specializations needed to develop new routines and risk-strategy protocols. Those restrictions have also impacted the urologic community. Several medical organisations developed specific information-hubs, blogs and resource centers on how to tackle the COVID-19 situation (1-3). Although the German Society of Urology (\"DGU\") has published a recommendation to evaluate the need for a timely therapy in prostate cancer (PCa) patients according to D'Amico risk groups on the 2(nd) of April 2020, up to now no compulsory directives exist regarding omitting radical prostatectomy (RP) during the COVID-19 pandemic."],"journal":"BJU Int","authors":["Wurnschimmel, Christoph","Maurer, Tobias","Knipper, Sophie","von Breunig, Franziska","Zoellner, Christian","Thederan, Imke","Huland, Hartwig","Graefen, Markus","Michl, Uwe"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32424990","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1111/bju.15115","keywords":["covid-19","coronavirus disease 2019","prostate cancer","radical prostatectomy","sars-cov-2"],"topics":["Prevention"],"weight":1,"_version_":1667252837783961601,"score":230.88554},{"pmid":32391666,"title":"[Roles of multidisciplinary team in diagnosis and treatment of suspected cases of COVID-19].","text":["[Roles of multidisciplinary team in diagnosis and treatment of suspected cases of COVID-19].","OBJECTIVE: To analyze the roles of multidisciplinary team (MDT) in the diagnosis and treatment of suspected cases of coronavirus disease 2019 (COVID-19). METHODS: The clinical data of 48 patients with suspected COVID-19 admitted in Jinhua Municipal Central Hospital from January 21, 2020 to March 20, 2020 were retrospectively analyzed. RESULTS: In the 48 suspected cases, 18 were diagnosed with COVID-19, and 30 were excluded. Each of the confirmed cases were discussed among MDT for 2 to 12 times with an average of (4.7+/-3.2) times; while for non-COVID-19 patients were discussed for 2 to 4 times with an average of (2.3+/-0.6) times. With the guidance of MDT, one COVID-19 patient was transferred to designated provincial hospital after effective treatment; one patient complicated with acute cholecystitis underwent gallbladder puncture and drainage; and COVID-19 was excluded in a highly suspected patient after alveolar lavage fluid examination. Except one transferred patient, all 17 confirmed COVID-19 patients were cured and discharged. There was no cross-infection occurred in suspected patients during the hospitalization. There were no deaths and no medical staff infections. CONCLUSIONS: The efficiency of diagnosis and treatment for suspected COVID-19 patients can be improved with MDT, particularly for complicated cases.","Zhejiang Da Xue Xue Bao Yi Xue Ban","Ding, Shubo","Yu, Shi'an","Chen, Haijun","Zhang, Dehe","Xu, Yejin","Zhu, Dan","Cheng, Kun","32391666"],"abstract":["OBJECTIVE: To analyze the roles of multidisciplinary team (MDT) in the diagnosis and treatment of suspected cases of coronavirus disease 2019 (COVID-19). METHODS: The clinical data of 48 patients with suspected COVID-19 admitted in Jinhua Municipal Central Hospital from January 21, 2020 to March 20, 2020 were retrospectively analyzed. RESULTS: In the 48 suspected cases, 18 were diagnosed with COVID-19, and 30 were excluded. Each of the confirmed cases were discussed among MDT for 2 to 12 times with an average of (4.7+/-3.2) times; while for non-COVID-19 patients were discussed for 2 to 4 times with an average of (2.3+/-0.6) times. With the guidance of MDT, one COVID-19 patient was transferred to designated provincial hospital after effective treatment; one patient complicated with acute cholecystitis underwent gallbladder puncture and drainage; and COVID-19 was excluded in a highly suspected patient after alveolar lavage fluid examination. Except one transferred patient, all 17 confirmed COVID-19 patients were cured and discharged. There was no cross-infection occurred in suspected patients during the hospitalization. There were no deaths and no medical staff infections. CONCLUSIONS: The efficiency of diagnosis and treatment for suspected COVID-19 patients can be improved with MDT, particularly for complicated cases."],"journal":"Zhejiang Da Xue Xue Bao Yi Xue Ban","authors":["Ding, Shubo","Yu, Shi'an","Chen, Haijun","Zhang, Dehe","Xu, Yejin","Zhu, Dan","Cheng, Kun"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32391666","source":"PubMed","week":"202020|May 11 - May 17","topics":["Treatment","Diagnosis"],"weight":1,"_version_":1666528580025188353,"score":229.15327},{"pmid":32484380,"title":"Time for a Paradigm Shift in Head and Neck Cancer Management During the COVID-19 Pandemic.","text":["Time for a Paradigm Shift in Head and Neck Cancer Management During the COVID-19 Pandemic.","OBJECTIVE: The coronavirus disease 2019 (COVID-19) pandemic has caused physicians and surgeons to consider restructuring traditional cancer management paradigms. We aim to review the current evidence regarding the diagnosis and management of head and neck cancer, with an emphasis on the role of the multidisciplinary team (MDT) during a pandemic. DATA SOURCES: COVID-19 resources from PubMed, Google Scholar, the American Academy of Otolaryngology-Head and Neck Surgery, and the American Head and Neck Society were examined. REVIEW METHODS: Studies and guidelines related to the multidisciplinary management of head and neck cancer in the COVID-19 setting were reviewed. A total of 54 studies were included. Given the continuously evolving body of literature, the sources cited include the latest statements from medical and dental societies. RESULTS: The unpredictable fluctuation of hospital resources and the risk of the nosocomial spread of SARS-CoV-2 have direct effects on head and neck cancer management. Using an MDT approach to help define \"essential surgery\" for immediately life- or function-threatening disease processes in the context of available hospital resources will help to maximize outcomes. Early enrollment in an MDT is often critical for considering nonsurgical options to protect patients and health care workers. The role of the MDT continues after cancer treatment, if delivered, and the MDT plays an essential role in surveillance and survivorship programs in these challenging times. CONCLUSION: Head and neck cancer management during the COVID-19 pandemic poses a unique challenge for all specialists involved. Early MDT involvement is important to maximize patient outcomes and satisfaction in the context of public and community safety.","Otolaryngol Head Neck Surg","Han, Albert Y","Miller, Jessa E","Long, Jennifer L","St John, Maie A","32484380"],"abstract":["OBJECTIVE: The coronavirus disease 2019 (COVID-19) pandemic has caused physicians and surgeons to consider restructuring traditional cancer management paradigms. We aim to review the current evidence regarding the diagnosis and management of head and neck cancer, with an emphasis on the role of the multidisciplinary team (MDT) during a pandemic. DATA SOURCES: COVID-19 resources from PubMed, Google Scholar, the American Academy of Otolaryngology-Head and Neck Surgery, and the American Head and Neck Society were examined. REVIEW METHODS: Studies and guidelines related to the multidisciplinary management of head and neck cancer in the COVID-19 setting were reviewed. A total of 54 studies were included. Given the continuously evolving body of literature, the sources cited include the latest statements from medical and dental societies. RESULTS: The unpredictable fluctuation of hospital resources and the risk of the nosocomial spread of SARS-CoV-2 have direct effects on head and neck cancer management. Using an MDT approach to help define \"essential surgery\" for immediately life- or function-threatening disease processes in the context of available hospital resources will help to maximize outcomes. Early enrollment in an MDT is often critical for considering nonsurgical options to protect patients and health care workers. The role of the MDT continues after cancer treatment, if delivered, and the MDT plays an essential role in surveillance and survivorship programs in these challenging times. CONCLUSION: Head and neck cancer management during the COVID-19 pandemic poses a unique challenge for all specialists involved. Early MDT involvement is important to maximize patient outcomes and satisfaction in the context of public and community safety."],"journal":"Otolaryngol Head Neck Surg","authors":["Han, Albert Y","Miller, Jessa E","Long, Jennifer L","St John, Maie A"],"date":"2020-06-03T11:00:00Z","year":2020,"_id":"32484380","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1177/0194599820931789","keywords":["covid-19","cancer management","head and neck cancer","multidisciplinary cancer","survivorship"],"topics":["Prevention"],"weight":1,"_version_":1668532114740477952,"score":223.85364},{"pmid":32275128,"title":"[Roles of multidisciplinary team (MDT) in diagnosis and treatment of suspected cases of corona virus disease 2019 (COVID-19)].","text":["[Roles of multidisciplinary team (MDT) in diagnosis and treatment of suspected cases of corona virus disease 2019 (COVID-19)].","OBJECTIVE: To analyze the roles of multidisciplinary team (MDT) in the diagnosis and treatment of suspected cases of corona virus disease 2019 (COVID-19). METHODS: The clinical data of 48 patients with suspected COVID-19 admitted in Jinhua Central Hospital from January 21, 2020 to March 20, 2020 were retrospectively analyzed. RESULTS: Of the 48 suspected cases, 18 were diagnosed with COVID-19, and 30 were excluded. Each of the confirmed cases were discussed among MDT for 2 to 12 times with an average of (4.7+/-3.2) times; while for non-COVID-19 patients were discussed for 2 to 4 times with an average of (2.3+/-0.6) times per case. With the guidance of MDT, one COVID-19 patient was transferred to designated provincial hospital after effective treatment; one patient complicated with acute cholecystitis underwent gallbladder puncture and drainage; and COVID-19 was excluded in a highly suspected patient after alveolar lavage fluid examination. Except one transferred patient, all 17 confirmed COVID-19 patients were cured and discharged; there was no cross-infection occurred in suspected patients during the hospitalization; there were no deaths and no medical staff infections. CONCLUSIONS: The efficiency of diagnosis and treatment for suspected COVID-19 patients can be improved under MDT mode, particularly for complicated and refractory cases.","Zhejiang Da Xue Xue Bao Yi Xue Ban","Ding, Shubo","Yu, Shi'an","Chen, Haijun","Zhang, Dehe","Xu, Yejin","Zhu, Dan","Cheng, Kun","32275128"],"abstract":["OBJECTIVE: To analyze the roles of multidisciplinary team (MDT) in the diagnosis and treatment of suspected cases of corona virus disease 2019 (COVID-19). METHODS: The clinical data of 48 patients with suspected COVID-19 admitted in Jinhua Central Hospital from January 21, 2020 to March 20, 2020 were retrospectively analyzed. RESULTS: Of the 48 suspected cases, 18 were diagnosed with COVID-19, and 30 were excluded. Each of the confirmed cases were discussed among MDT for 2 to 12 times with an average of (4.7+/-3.2) times; while for non-COVID-19 patients were discussed for 2 to 4 times with an average of (2.3+/-0.6) times per case. With the guidance of MDT, one COVID-19 patient was transferred to designated provincial hospital after effective treatment; one patient complicated with acute cholecystitis underwent gallbladder puncture and drainage; and COVID-19 was excluded in a highly suspected patient after alveolar lavage fluid examination. Except one transferred patient, all 17 confirmed COVID-19 patients were cured and discharged; there was no cross-infection occurred in suspected patients during the hospitalization; there were no deaths and no medical staff infections. CONCLUSIONS: The efficiency of diagnosis and treatment for suspected COVID-19 patients can be improved under MDT mode, particularly for complicated and refractory cases."],"journal":"Zhejiang Da Xue Xue Bao Yi Xue Ban","authors":["Ding, Shubo","Yu, Shi'an","Chen, Haijun","Zhang, Dehe","Xu, Yejin","Zhu, Dan","Cheng, Kun"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32275128","source":"PubMed","week":"202015|Apr 06 - Apr 12","topics":["Treatment","Diagnosis"],"weight":1,"_version_":1666138491678883843,"score":219.47957}]}